经导管主动脉瓣置换术后主动脉瓣再干预的回顾性分析
该研究回顾了2011至2019年在密歇根大学接受TAVR的1487例患者,其中24例(1.6%)需主动脉瓣再干预,另纳入4例外院TAVR后在本院再干预者,共分析28例。再干预主要原因为结构性瓣膜退化(39%)和瓣周漏(36%),8年累积再干预发生率为4.6%。多数(71%)因需同期心脏手术、解剖不利或感染性心内膜炎而不适合重复TAVR。
要点
- TAVR术后再干预率低,8年累积发生率为4.6%。
- 再干预主因为结构性瓣膜退化(39%)和瓣周漏(36%)。
- 71%不适合重复TAVR,多因需同期手术或解剖不利。
核心结论
- 重复TAVR常因解剖不利和/或需同期心脏手术而不可行。
- 初始TAVR术前应仔细评估瓣膜重复可操作性,尤其对年轻患者。
研究设计与样本
- 单中心回顾性研究,纳入2011至2019年密歇根大学1487例TAVR患者中24例(1.6%)再干预者,另加4例外院TAVR后本院再干预者,共28例。
主要发现
- 再干预中位年龄72岁,女性占36%,86%植入的TAVR装置为自膨胀瓣。
- 再干预主要适应证为结构性瓣膜退化(39%)和瓣周漏(36%)。
- 8年主动脉瓣再干预累积发生率为4.6%。
- 71%因需同期心脏手术(50%)、解剖不利(45%)或感染性心内膜炎(10%)而不适合重复TAVR。
- TAVR瓣膜取出常伴同期手术:主动脉修复(35%)、二尖瓣修复/置换(35%)、三尖瓣修复(25%)、冠状动脉旁路移植(20%)。
关键数值与推荐
- 71%的主动脉手术为计划外但因装置与接触组织严重粘连而必要。
- TAVR瓣膜取出组院内死亡3例(15%),重复TAVR组无死亡。
临床怎么用
- 初始TAVR术前应评估瓣膜重复可操作性,尤其对年轻患者。
- 再干预决策需考虑解剖适宜性及是否需同期心脏手术。
局限性
- 单中心回顾性研究,样本量小(28例),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the rapid adoption of transcatheter aortic valve replacement (TAVR), there are scant data regarding aortic valve reintervention after initial TAVR. METHODS: Between 2011 and 2019, 1487 patients underwent a TAVR at the University of Michigan. Among these, 24 (1.6%) patients required an aortic valve reintervention. Additionally, 4 patients who received a TAVR at another institution underwent a valve reintervention at our institution. We retrospectively reviewed these 28 patients. RESULTS: The median age was 72 years, 36% were female and 86% of implanted TAVR devices were self-expandable. The leading indications for reintervention were structural valve degeneration (39%) and paravalvular leak (36%). The cumulative incidence of aortic valve reintervention was 4.6% at 8 years. Most (71%) were deemed unsuitable for repeat TAVR because of the need for concurrent cardiac procedures (50%), unfavorable anatomy (45%), or endocarditis (10%). TAVR valve explant was associated with frequent concurrent procedures, consisting of aortic repair (35%), mitral repair/replacement (35%), tricuspid repair (25%), and coronary artery bypass graft (20%). Seventy-one percent of aortic procedures were unplanned but proved necessary because of severe adhesion of the devices to the contacting tissue. There were 3 (15%) in-hospital mortalities in the TAVR valve explant group, whereas there was no mortality in the repeat TAVR group. CONCLUSIONS: Repeat TAVR procedure was frequently not feasible because of unfavorable anatomy and/or the need for concurrent cardiac procedures. Careful assessment of TAVR procedure repeatability should be weighed at the initial TAVR workup especially in younger patients who are expected to require a valve reintervention.
引用
- Fukuhara S, Nguyen CTN, Kim KM, et al. Aortic valve reintervention after transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2021. PMID: 34364682. doi:10.1016/j.jtcvs.2021.03.130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。